Type of Care:
Substance use treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.):
Outpatient Outpatient methadone/buprenorphine or naltrexone treatment
Opioid Medications used in Treatment:
Buprenorphine used in Treatment Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment:
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment:
In-network prescribing entity
Type of Opioid Treatment:
Buprenorphine maintenance Prescribes buprenorphine Prescribes naltrexone
Pharmacotherapies:
Buprenorphine with naloxone Buprenorphine without naloxone Naltrexone (extended-release, injectable)
Treatment Approaches:
Relapse prevention Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public):
Private for-profit organization
License/Certification/Accreditation:
State Substance use treatment agency State department of health SAMHSA certification for opioid treatment program (OTP) Drug Enforcement Agency (DEA)
Assessment/Pre-treatment:
Comprehensive substance use assessment Complete medical history/physical exam Screening for tobacco use Screening for substance use
Testing:
Drug or alcohol urine screening HIV testing Metabolic syndrome monitoring Testing for Hepatitis B (HBV) Testing for Hepatitis C (HCV)
Transitional Services:
Naloxone and overdose education
Education and Counseling Services:
Substance use disorder education
Facility Smoking Policy :
Smoking not permitted
Age Groups Accepted:
Young Adults Adults
Facility Vaping Policy:
Vaping permitted without restriction